TTM
$1.80B
YoY change
+5.4%
5Y CAGR
+23.8%
Peak year (2025)
$1.78B
Cumulative EBITDA
$13.86B
EBITDA history chart for Xylem (XYL) from 2009 to 2025
Latest: $1.78B
EBITDA growth chart for Xylem (XYL) from 2009 to 2025
Latest: +5.4%
EBITDA history table for Xylem (XYL) from 2009 to 2025
| 2025 | $1.78B | +5.4% | +$92.00M | ||
| 2024 | $1.69B | +51.2% | +$573.00M | ||
| 2023 | $1.12B | +54.3% | +$394.00M | ||
| 2022 | $726.00M | -12.7% | −$106.00M | ||
| 2021 | $832.00M | +35.7% | +$219.00M | ||
| 2020 | $613.00M | -17.2% | −$127.00M | ||
| 2019 | $740.00M | -20.3% | −$188.00M | ||
| 2018 | $928.00M | +18.7% | +$146.00M | ||
| 2017 | $782.00M | +39.4% | +$221.00M | ||
| 2016 | $561.00M | -5.1% | −$30.00M | ||
| 2015 | $591.00M | -4.2% | −$26.00M | ||
| 2014 | $617.00M | +22.7% | +$114.00M | ||
| 2013 | $503.00M | -14.0% | −$82.00M | ||
| 2012 | $585.00M | +8.9% | +$48.00M | ||
| 2011 | $537.00M | +11.9% | +$57.00M | ||
| 2010 | $480.00M | +27.3% | +$103.00M | ||
| 2009 | $377.00M | — | — |
- 2025$1.78B+5.4%
- 2024$1.69B+51.2%
- 2023$1.12B+54.3%
- 2022$726.00M-12.7%
- 2021$832.00M+35.7%
- 2020$613.00M-17.2%
- 2019$740.00M-20.3%
- 2018$928.00M+18.7%
- 2017$782.00M+39.4%
- 2016$561.00M-5.1%
- 2015$591.00M-4.2%
- 2014$617.00M+22.7%
- 2013$503.00M-14.0%
- 2012$585.00M+8.9%
- 2011$537.00M+11.9%
- 2010$480.00M+27.3%
- 2009$377.00M—
EBITDA values are taken from Xylem's reported income statements (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
About EBITDA at Xylem (XYL)
According to Xylem's latest reported financial statements, the company's current EBITDA (TTM) is $1.80B. EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a common proxy for operating cash generation that strips out non-cash charges (depreciation and amortization) and capital structure effects (interest, taxes). Useful for comparing companies with different leverage and asset bases — see operating income and net income for fully GAAP figures.
Headline TTM above sums the four reported quarters through (reported ). Chart and table below cover the full reported history back to .
As of the 2025 fiscal year, Xylem (XYL) reported EBITDA of $1.78B – grew 5.4% year-over-year.
Through 2020–2025 (5 years), Xylem EBITDA delivered a +23.8% annualised rate; sustaining 3 straight years of year-over-year growth.
2025 marks the peak EBITDA at $1.78B, with the historical low of $377.00M recorded in 2009.
Xylem EBITDA by Year
Xylem EBITDA 2025: $1.78B
In 2025, Xylem reported EBITDA of $1.78B, grew 5.4% from 2024. This figure represents the highest annual value in the available history.
Xylem EBITDA 2024: $1.69B
Xylem EBITDA in 2024 was $1.69B, surged 51.2% from 2023.
Xylem EBITDA 2023: $1.12B
2023's EBITDA for Xylem came in at $1.12B, surged 54.3% from 2022.
Xylem EBITDA 2022: $726.00M
Xylem posted EBITDA of $726.00M in 2022, declined 12.7% below 2021.
Xylem EBITDA 2021: $832.00M
Xylem EBITDA in 2021 was $832.00M.
See more financial history for Xylem (XYL).
Sector peers by EBITDA
Industrials peers of Xylem (XYL), ranked by their latest EBITDA
| $14.95B | |
| $14.86B | |
| $12.95B | |
| $12.06B | |
| $11.66B | |
| $7.36B | |
| $5.95B | |
| $4.29B |
- $14.95B
- $14.86B
- $12.95B
- $12.06B
- $11.66B
- $7.36B
- $5.95B
- $4.29B
Frequently asked questions
Xylem (XYL) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation